Skip Navigation



Rheumatology Advance Access published online on August 24, 2004
Rheumatology, doi:10.1093/rheumatology/keh364
Rheumatology © British Society for Rheumatology 2004; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/1/3    most recent
keh364v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bansback, N. J.
Right arrow Articles by Brennan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bansback, N. J.
Right arrow Articles by Brennan, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

The NICE reappraisal of biologics in 2005: what rheumatologists need to know

N. J. Bansback 1, A. Young 2, A. Brennan 1*

1 Operational Research, School of Health and Related Research, Sheffield S1 4DA, UK
2 Early Rheumatoid Arthritis Study (ERAS) Co-ordinator, St Albans Hospital, St Albans AL3 5PN, UK

* To whom correspondence should be addressed. E-mail: a.brennan{at}sheffield.ac.uk.


  Abstract

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
C. Deighton and K. Hyrich
Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement
Rheumatology, November 1, 2008; 47(11): 1600 - 1602.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. Brennan, N. Bansback, R. Nixon, J. Madan, M. Harrison, K. Watson, and D. Symmons
Modelling the cost effectiveness of TNF-{alpha} antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry
Rheumatology, August 1, 2007; 46(8): 1345 - 1354.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.